Want to see KR:002630 full AI Analyst Report?
ORIENTBIO, Inc. (002630) Financial Statements
ORIENTBIO, Inc. Financial Overview
ORIENTBIO, Inc.'s market cap is currently $35.26B. The company's EPS TTM is $77.98; its P/E ratio is 15.26; ORIENTBIO, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 29.75B | $ 29.40B | $ 28.01B | $ 28.82B | $ 26.28B |
| Gross Profit | $ 3.96B | $ 7.20B | $ 9.58B | $ 9.82B | $ 9.01B |
| Operating Income | $ -4.44B | $ -3.08B | $ -645.95M | $ 1.45B | $ -3.78B |
| EBITDA | $ -2.24B | $ -11.02B | $ 15.67B | $ -9.25B | $ 997.25M |
| Net Income | $ -4.57B | $ -13.19B | $ 12.87B | $ -12.42B | $ 34.20B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 32.77B | $ 32.53B | $ 41.23B | $ 35.47B | $ 59.04B |
| Total Assets | $ 81.62B | $ 84.78B | $ 96.99B | $ 81.05B | $ 104.95B |
| Total Debt | $ 1.94B | $ 2.62B | $ 3.04B | $ 847.75M | $ 7.40B |
| Net Debt | $ -3.90B | $ -3.91B | $ -3.07B | $ -5.09B | $ -22.60B |
| Total Liabilities | $ 13.07B | $ 12.94B | $ 11.89B | $ 9.66B | $ 21.76B |
| Stockholders' Equity | $ 68.54B | $ 71.85B | $ 85.10B | $ 71.39B | $ 83.19B |
| Cash Flow | |||||
| Free Cash Flow | $ 547.86M | $ -4.04B | $ 2.83B | $ 674.30M | $ 140.53M |
| Operating Cash Flow | $ 2.60B | $ 752.29M | $ 3.76B | $ 1.16B | $ 2.35B |
| Investing Cash Flow | $ -2.62B | $ 315.65M | $ -3.12B | $ -20.66B | $ 16.77B |
| Financing Cash Flow | $ -688.56M | $ -839.60M | $ -570.35M | $ -6.79B | $ -1.13B |
Currency in KRW